Keramed distribution rights

Keramed distribution rights

Ziemer Ophthalmic Systems AG has announced that it has obtained exclusive rights for distribution in Germany, Switzerland and Austria of the KeraKlear artificial cornea and the EndoInjector from Keramed Inc, Sunnyvale, California. The KeraKlear Artificial Cornea is a medical device for the treatment of corneal blindness which can be implanted in the eye through a very small incision. The EndoInjector (previously known as the EndoShield) is the latest generation device to enable delivery of a corneal graft for Descemet's Stripping Endothelial Keratoplasty (DSEK). 'The KeraKlear Artificial Cornea and EndoInjector have CE approval. No regulatory clearance is available for either product in the US. Market introduction of both products in Germany, Switzerland and Austria is scheduled for autumn 2012,' said a company spokeswoman.  

www.ziemergroup.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...